Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial-Reference-Cited by-同舟云学术

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

Published:2009-02 Issue:2 Volume:10 Page:135-146
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Kenemans Peter,Bundred Nigel J,Foidart Jean-Michel,Kubista Ernst,von Schoultz Bo,Sismondi Piero,Vassilopoulou-Sellin Rena,Yip Cheng Har,Egberts Jan,Mol-Arts Mirjam,Mulder Roel,van Os Steve,Beckmann Matthias W

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer;Howell;Lancet,2005

2. Risk of menopause during the first year after breast cancer diagnosis;Goodwin;J Clin Oncol,1999

3. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach;Hickey;Lancet Oncol,2005

4. Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk;Col;J Clin Oncol,2001

5. Tibolone for postmenopausal women: systematic review of randomized trials;Modelska;J Clin Endocrinol Metab,2002

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor;Menopause;2024-08-21

2. Managing sexual health challenges in breast cancer survivors: A comprehensive review;The Breast;2024-08

3. Hormonersatztherapie in der Peri- und Postmenopause und Krebsrisiko;Die Gynäkologie;2024-06-19

4. Endocrine consequences of breast cancer therapy and survivorship;Climacteric;2024-06-12

5. Yoga and meditation for menopausal symptoms in breast cancer survivors: a qualitative study exploring participants’ experiences;Supportive Care in Cancer;2024-06-06